Children affected by the brain tumour known as ACP can have a positive future, but in many cases their quality of life isn’t as good as it could be. New, targeted treatments are needed, and this collaborative project brings together teams from the UK and Germany to profile these tumours and work towards the development of improved treatments.
Our funding is enabling doctors to identify the genetic profile of brain tumours known as ACP, and then work towards the development of new therapies and treatments for the disease.
Molecular Characterisation and Assessment of Potential Biomarkers and Novel Drug Targets for Childhood Craniopharyngioma
Dr Juan Pedro Martinez-Barbera
Institute of Child Health, University College London
London, WC1N 1EH
13 January 2016